chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Fatigue, Nausea, Vaccination site bruising
Clinical narrative: Chest Pressure; Little cough; Vccination site brusing; Vaccination site erythema; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest Pressure), COUGH (Little cough), VACCINATION SITE BRUISING (Vccination site brusing), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and FATIGUE (Fatigue) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis (Took Enbrel for Rheumatoid Arthritis). Concomitant products included PREDNISONE, WARFARIN and AMLODIPINE, METOPROLOL SUCCINATE (TOPROLOL AM) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced CHEST DISCOMFORT (Chest Pressure), COUGH (Little cough), VACCINATION SITE BRUISING (Vccination site brusing), VACCINATION SITE ERYTHEMA (Vaccination site erythema), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, CHEST DISCOMFORT (Chest Pressure), COUGH (Little cough), VACCINATION SITE BRUISING (Vccination site brusing), VACCINATION SITE ERYTHEMA (Vaccination site erythema), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Chest Pressure; Little cough; Vccination site brusing; Vaccination site erythema; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest Pressure), COUGH (Little cough), VACCINATION SITE BRUISING (Vccination site brusing), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and FATIGUE (Fatigue) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis (Took Enbrel for Rheumatoid Arthritis). Concomitant products included PREDNISONE, WARFARIN and AMLODIPINE, METOPROLOL SUCCINATE (TOPROLOL AM) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced CHEST DISCOMFORT (Chest Pressure), COUGH (Little cough), VACCINATION SITE BRUISING (Vccination site brusing), VACCINATION SITE ERYTHEMA (Vaccination site erythema), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, CHEST DISCOMFORT (Chest Pressure), COUGH (Little cough), VACCINATION SITE BRUISING (Vccination site brusing), VACCINATION SITE ERYTHEMA (Vaccination site erythema), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: injection site itchiness; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE ERYTHEMA (injection site redness) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE ERYTHEMA (injection site redness). At the time of the report, VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE ERYTHEMA (injection site redness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment included antibiotic ointment.   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Mass
Clinical narrative: Bump under her right breast; This spontaneous case was reported by a physician and describes the occurrence of MASS (Bump under her right breast) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced MASS (Bump under her right breast). At the time of the report, MASS (Bump under her right breast) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken in response to mRNA-1273 was not applicable. Concomitant product use was not provided. No treatment was reported.
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Injury
Clinical narrative: Doesn't seem to know what's going on since post-vaccination; Last 2 weeks ago and began bumping into stuff; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Doesn't seem to know what's going on since post-vaccination) and INJURY (Last 2 weeks ago and began bumping into stuff) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (Doesn't seem to know what's going on since post-vaccination) and INJURY (Last 2 weeks ago and began bumping into stuff). At the time of the report, CONFUSIONAL STATE (Doesn't seem to know what's going on since post-vaccination) and INJURY (Last 2 weeks ago and began bumping into stuff) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dizziness postural, Fall
Clinical narrative: lightheaded; dizzy when standing; falls down; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded), DIZZINESS POSTURAL (dizzy when standing) and FALL (falls down) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (lightheaded), DIZZINESS POSTURAL (dizzy when standing) and FALL (falls down). At the time of the report, DIZZINESS (lightheaded), DIZZINESS POSTURAL (dizzy when standing) and FALL (falls down) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.     Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow-up information received, contains reporters contact details and outcome for events as recovered.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma
Clinical narrative: Asthmatic Attack; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthmatic Attack) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Asthma since an unknown date. Concomitant products included Asthma Inhaler for Asthma, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY), ANTIDEPRESSANTS and VITAMINS NOS for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ASTHMA (Asthmatic Attack). At the time of the report, ASTHMA (Asthmatic Attack) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Steroid pill 4 mg and levofloxacin.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site). At the time of the report, VACCINATION SITE RASH (Rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Burning sensation, Cold-stimulus headache, Head discomfort, Headache
Clinical narrative: Headache, feel stabbing pains in my head; Pressure and burning in head; Pressure and burning in head; feels like my brain has the chills; my brain feels like it's shaking in my head; Arm sore at injection site; Termperature 99.9 degrees F; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Pressure and burning in head), BURNING SENSATION (Pressure and burning in head), COLD-STIMULUS HEADACHE (feels like my brain has the chills), NERVOUSNESS (my brain feels like it's shaking in my head) and VACCINATION SITE PAIN (Arm sore at injection site) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0132L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced HEAD DISCOMFORT (Pressure and burning in head), BURNING SENSATION (Pressure and burning in head), COLD-STIMULUS HEADACHE (feels like my brain has the chills), NERVOUSNESS (my brain feels like it's shaking in my head), VACCINATION SITE PAIN (Arm sore at injection site) and PYREXIA (Termperature 99.9 degrees F). On 16-Jan-2021, the patient experienced HEADACHE (Headache, feel stabbing pains in my head). At the time of the report, HEAD DISCOMFORT (Pressure and burning in head), BURNING SENSATION (Pressure and burning in head), COLD-STIMULUS HEADACHE (feels like my brain has the chills), NERVOUSNESS (my brain feels like it's shaking in my head), VACCINATION SITE PAIN (Arm sore at injection site), PYREXIA (Termperature 99.9 degrees F) and HEADACHE (Headache, feel stabbing pains in my head) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: other (High) 99.9 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nervousness, Pyrexia, Vaccination site pain
Clinical narrative: Headache, feel stabbing pains in my head; Pressure and burning in head; Pressure and burning in head; feels like my brain has the chills; my brain feels like it's shaking in my head; Arm sore at injection site; Termperature 99.9 degrees F; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Pressure and burning in head), BURNING SENSATION (Pressure and burning in head), COLD-STIMULUS HEADACHE (feels like my brain has the chills), NERVOUSNESS (my brain feels like it's shaking in my head) and VACCINATION SITE PAIN (Arm sore at injection site) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0132L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced HEAD DISCOMFORT (Pressure and burning in head), BURNING SENSATION (Pressure and burning in head), COLD-STIMULUS HEADACHE (feels like my brain has the chills), NERVOUSNESS (my brain feels like it's shaking in my head), VACCINATION SITE PAIN (Arm sore at injection site) and PYREXIA (Termperature 99.9 degrees F). On 16-Jan-2021, the patient experienced HEADACHE (Headache, feel stabbing pains in my head). At the time of the report, HEAD DISCOMFORT (Pressure and burning in head), BURNING SENSATION (Pressure and burning in head), COLD-STIMULUS HEADACHE (feels like my brain has the chills), NERVOUSNESS (my brain feels like it's shaking in my head), VACCINATION SITE PAIN (Arm sore at injection site), PYREXIA (Termperature 99.9 degrees F) and HEADACHE (Headache, feel stabbing pains in my head) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: other (High) 99.9 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itchiness; rashes on both arms and Palms; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness) and RASH (rashes on both arms and Palms) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced RASH (rashes on both arms and Palms). On an unknown date, the patient experienced PRURITUS (itchiness). At the time of the report, PRURITUS (itchiness) had not resolved and RASH (rashes on both arms and Palms) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Choking sensation, Dyspnoea
Clinical narrative: Shortness of breath; Felt like someone was choking his throat; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) and CHOKING SENSATION (Felt like someone was choking his throat) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced DYSPNOEA (Shortness of breath) and CHOKING SENSATION (Felt like someone was choking his throat). On 23-Jan-2021, DYSPNOEA (Shortness of breath) and CHOKING SENSATION (Felt like someone was choking his throat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported.    Treatment information was not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema mouth, Peripheral swelling
Clinical narrative: her upper lip, mouth, tongue and throat got swollen; Swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of OEDEMA MOUTH (her upper lip, mouth, tongue and throat got swollen) and PERIPHERAL SWELLING (Swollen arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028120A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced OEDEMA MOUTH (her upper lip, mouth, tongue and throat got swollen) and PERIPHERAL SWELLING (Swollen arm). On 04-Feb-2021, PERIPHERAL SWELLING (Swollen arm) had resolved. At the time of the report, OEDEMA MOUTH (her upper lip, mouth, tongue and throat got swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter  No treatment medications provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 16-Feb-2021: No specific follow-up information recorded.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure measurement, Chills, Heart rate, Heart rate increased
Clinical narrative: Heart was racing /pounding; Heart rate when up; WEAK; warm to touch; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart was racing /pounding), HEART RATE INCREASED (Heart rate when up), ASTHENIA (WEAK), SKIN WARM (warm to touch) and CHILLS (Chills) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PALPITATIONS (Heart was racing /pounding), HEART RATE INCREASED (Heart rate when up), ASTHENIA (WEAK), SKIN WARM (warm to touch) and CHILLS (Chills). At the time of the report, PALPITATIONS (Heart was racing /pounding), HEART RATE INCREASED (Heart rate when up), ASTHENIA (WEAK), SKIN WARM (warm to touch) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Blood pressure measurement: 160 (Inconclusive) 160. On 22-Jan-2021, Heart rate: 118 (Inconclusive) 118.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included enlarged prostate, eyedrops for glaucoma and aspirin.  Treatment details not reported by the reported.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations, Skin warm
Clinical narrative: Heart was racing /pounding; Heart rate when up; WEAK; warm to touch; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart was racing /pounding), HEART RATE INCREASED (Heart rate when up), ASTHENIA (WEAK), SKIN WARM (warm to touch) and CHILLS (Chills) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PALPITATIONS (Heart was racing /pounding), HEART RATE INCREASED (Heart rate when up), ASTHENIA (WEAK), SKIN WARM (warm to touch) and CHILLS (Chills). At the time of the report, PALPITATIONS (Heart was racing /pounding), HEART RATE INCREASED (Heart rate when up), ASTHENIA (WEAK), SKIN WARM (warm to touch) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Blood pressure measurement: 160 (Inconclusive) 160. On 22-Jan-2021, Heart rate: 118 (Inconclusive) 118.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included enlarged prostate, eyedrops for glaucoma and aspirin.  Treatment details not reported by the reported.
Sex: U
Vaccine: COVID19
Symptoms: Product contamination physical
Clinical narrative: Doses were administered from a vial with slight solid particles; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT CONTAMINATION PHYSICAL (Doses were administered from a vial with slight solid particles) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 9:07 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PRODUCT CONTAMINATION PHYSICAL (Doses were administered from a vial with slight solid particles). On 21-Feb-2021, PRODUCT CONTAMINATION PHYSICAL (Doses were administered from a vial with slight solid particles) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 12 Feb 2021, six doses were administered from a vial with slight solid particulates was noted clinging to the side of the vial. Dosage administration was suspended from this vial and after the vial was rested for 20 minutes at room temperature, the particulate disappeared.  No concomitant medication were provided.  No treatment information were provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow up received on 13-Jul-2021 appended to AER, new reporter added, batch number and clinical course of the narrative was updated.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Urticaria, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Hives; Itchy; Raised; Red; Slouchy; This spontaneous case was reported by an other health care professional and describes the occurrence of URTICARIA (Hives), ASTHENIA (Slouchy), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Raised) and VACCINATION SITE ERYTHEMA (Red) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included LOSARTAN for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Raised) and VACCINATION SITE ERYTHEMA (Red). On 11-Feb-2021, the patient experienced URTICARIA (Hives). On an unknown date, the patient experienced ASTHENIA (Slouchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) ongoing since an unknown date for Itching, at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives), ASTHENIA (Slouchy), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Raised) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 16-Feb-2021: No new information
Sex: U
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity, Vaccination site pain
Clinical narrative: Pain spread down side of arm to elbow; Pain in up side of neck; Arm starting hurting focalized at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain spread down side of arm to elbow), NECK PAIN (Pain in up side of neck) and VACCINATION SITE PAIN (Arm starting hurting focalized at injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain spread down side of arm to elbow), NECK PAIN (Pain in up side of neck) and VACCINATION SITE PAIN (Arm starting hurting focalized at injection site). At the time of the report, PAIN IN EXTREMITY (Pain spread down side of arm to elbow), NECK PAIN (Pain in up side of neck) and VACCINATION SITE PAIN (Arm starting hurting focalized at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment included ice and ibuprofen.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. No treatment information provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal loss of weight, Arthralgia, Chills, Fatigue, Headache
Clinical narrative: Could not hold urine; Lost 7 pounds; Vomited; Headache; felt fatigued; Chills; Muscle and joint pain; Muscle and joint pain; This spontaneous case was reported by a consumer and describes the occurrence of URINARY INCONTINENCE (Could not hold urine), ABNORMAL LOSS OF WEIGHT (Lost 7 pounds), VOMITING (Vomited), HEADACHE (Headache) and FATIGUE (felt fatigued) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Acid reflux (esophageal) and Hypertension. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), CELECOXIB (CELEBREX), ATORVASTATIN, LOSARTAN and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced URINARY INCONTINENCE (Could not hold urine), ABNORMAL LOSS OF WEIGHT (Lost 7 pounds), VOMITING (Vomited), HEADACHE (Headache), FATIGUE (felt fatigued), CHILLS (Chills), MYALGIA (Muscle and joint pain) and ARTHRALGIA (Muscle and joint pain). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 3 tablets every 3-4 hours. At the time of the report, URINARY INCONTINENCE (Could not hold urine), ABNORMAL LOSS OF WEIGHT (Lost 7 pounds), VOMITING (Vomited), HEADACHE (Headache), FATIGUE (felt fatigued), CHILLS (Chills), MYALGIA (Muscle and joint pain) and ARTHRALGIA (Muscle and joint pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Urinary incontinence, Vomiting
Clinical narrative: Could not hold urine; Lost 7 pounds; Vomited; Headache; felt fatigued; Chills; Muscle and joint pain; Muscle and joint pain; This spontaneous case was reported by a consumer and describes the occurrence of URINARY INCONTINENCE (Could not hold urine), ABNORMAL LOSS OF WEIGHT (Lost 7 pounds), VOMITING (Vomited), HEADACHE (Headache) and FATIGUE (felt fatigued) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Acid reflux (esophageal) and Hypertension. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), CELECOXIB (CELEBREX), ATORVASTATIN, LOSARTAN and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced URINARY INCONTINENCE (Could not hold urine), ABNORMAL LOSS OF WEIGHT (Lost 7 pounds), VOMITING (Vomited), HEADACHE (Headache), FATIGUE (felt fatigued), CHILLS (Chills), MYALGIA (Muscle and joint pain) and ARTHRALGIA (Muscle and joint pain). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 3 tablets every 3-4 hours. At the time of the report, URINARY INCONTINENCE (Could not hold urine), ABNORMAL LOSS OF WEIGHT (Lost 7 pounds), VOMITING (Vomited), HEADACHE (Headache), FATIGUE (felt fatigued), CHILLS (Chills), MYALGIA (Muscle and joint pain) and ARTHRALGIA (Muscle and joint pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Injection site rash, Oropharyngeal pain
Clinical narrative: Sore throat; Intermittent Cough; Rash on injection site (the size of a half dollar); This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), COUGH (Intermittent Cough) and INJECTION SITE RASH (Rash on injection site (the size of a half dollar)) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), COUGH (Intermittent Cough) and INJECTION SITE RASH (Rash on injection site (the size of a half dollar)). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), COUGH (Intermittent Cough) and INJECTION SITE RASH (Rash on injection site (the size of a half dollar)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Pyrexia
Clinical narrative: Trouble breathing feels like crack ribs; Fever above 102; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Trouble breathing feels like crack ribs) and PYREXIA (Fever above 102) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced PYREXIA (Fever above 102). On an unknown date, the patient experienced DYSPNOEA (Trouble breathing feels like crack ribs). The patient was treated with PARACETAMOL (TYNELOL) ongoing from 09-Feb-2021 at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Trouble breathing feels like crack ribs) and PYREXIA (Fever above 102) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter.   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included BISACODYL (LAXATIVE [BISACODYL]) for Bowel movement irregularity.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not reported by the reporter.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Feeling hot, Illness, Oropharyngeal pain
Clinical narrative: Sore throat; Face feels swollen and hot; face feels hot; Feverish and felt hot; so sick; very tired; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), SWELLING FACE (Face feels swollen and hot), FEELING HOT (face feels hot), ILLNESS (so sick) and FATIGUE (very tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced ILLNESS (so sick) and FATIGUE (very tired). On 30-Jan-2021, the patient experienced SWELLING FACE (Face feels swollen and hot), FEELING HOT (face feels hot) and PYREXIA (Feverish and felt hot). On 31-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), SWELLING FACE (Face feels swollen and hot), FEELING HOT (face feels hot) and PYREXIA (Feverish and felt hot) had not resolved and ILLNESS (so sick) and FATIGUE (very tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, Body temperature: 98.4 normal. In February 2021, SARS-CoV-2 test: (Positive) one week later after vaccination got tested positive..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Caucasian is the race of the patient. No concomitant medications were reported No treatment drugs were reported   Most recent FOLLOW-UP information incorporated above includes: On 17-Feb-2021: Additional initial document received on 17-FEB-2021 had added events like lab data
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Swelling face
Clinical narrative: Sore throat; Face feels swollen and hot; face feels hot; Feverish and felt hot; so sick; very tired; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), SWELLING FACE (Face feels swollen and hot), FEELING HOT (face feels hot), ILLNESS (so sick) and FATIGUE (very tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced ILLNESS (so sick) and FATIGUE (very tired). On 30-Jan-2021, the patient experienced SWELLING FACE (Face feels swollen and hot), FEELING HOT (face feels hot) and PYREXIA (Feverish and felt hot). On 31-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), SWELLING FACE (Face feels swollen and hot), FEELING HOT (face feels hot) and PYREXIA (Feverish and felt hot) had not resolved and ILLNESS (so sick) and FATIGUE (very tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, Body temperature: 98.4 normal. In February 2021, SARS-CoV-2 test: (Positive) one week later after vaccination got tested positive..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Caucasian is the race of the patient. No concomitant medications were reported No treatment drugs were reported   Most recent FOLLOW-UP information incorporated above includes: On 17-Feb-2021: Additional initial document received on 17-FEB-2021 had added events like lab data
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Coworker experienced migraines; This spontaneous case was reported by a health care professional and describes the occurrence of MIGRAINE (Coworker experienced migraines) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Coworker experienced migraines). At the time of the report, MIGRAINE (Coworker experienced migraines) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  No treatments were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: TCR received and included information to confirm that reporter did not receive the Moderna vaccine and had only mentioned a coworker that received Moderna with an AE of migraine.  Case updated to reflect this information.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Illness, Weight decreased
Clinical narrative: Was 200 lbs, but he went down to 181 lbs after getting covid; He got much sicker; This spontaneous case was reported by a health care professional and describes the occurrence of ILLNESS (He got much sicker) and WEIGHT DECREASED (Was 200 lbs, but he went down to 181 lbs after getting covid) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced ILLNESS (He got much sicker). On an unknown date, the patient experienced WEIGHT DECREASED (Was 200 lbs, but he went down to 181 lbs after getting covid). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of UNK dosage form and PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, ILLNESS (He got much sicker) had not resolved and WEIGHT DECREASED (Was 200 lbs, but he went down to 181 lbs after getting covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, COVID-19: positive (Positive) tested positive for covid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported.   This case was linked to MOD-2021-014947 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red and swollen area at injection site) and VACCINATION SITE SWELLING (Red and swollen area at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red and swollen area at injection site) and VACCINATION SITE SWELLING (Red and swollen area at injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red and swollen area at injection site) and VACCINATION SITE SWELLING (Red and swollen area at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication details were not reported by the reported. Treatment details not reported by the reporter.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Ultrasound scan
Clinical narrative: 1 week pregnant/ 5 weeks pregnant; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of EXPOSURE DURING PREGNANCY (1 week pregnant/ 5 weeks pregnant) in a 29-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 011J20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (Prior history of alcohol use ocassionally). Concomitant products included PARACETAMOL (TYLENOL) for Pain, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 29-Dec-2020 and the estimated date of delivery was 05-Oct-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (1 week pregnant/ 5 weeks pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (1 week pregnant/ 5 weeks pregnant) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Ultrasound scan: (normal) Normal Pregnancy.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Pregnancy details updated.
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Pyrexia
Clinical narrative: swollen eye; fever; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swollen eye) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE SWELLING (swollen eye) and PYREXIA (fever). At the time of the report, EYE SWELLING (swollen eye) and PYREXIA (fever) had resolved.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    Concomitant medications were not reported. Treatment information was not provided. As per source document, a follow-up conducted with consumer on 06-Jul-21, the outcome of all adverse events reported had been resolved.  Reporter did not allow further contact  Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Significant information received, outcome of the events updated and patient denied for further follow up.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants products were reported. No treatment information  was reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: TCR- received on 24-apr-2021. Outcome of the event updated from unknown to not recovered/not resolved.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasal congestion
Clinical narrative: cough; nasal congestion; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) and NASAL CONGESTION (nasal congestion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030620A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced COUGH (cough) and NASAL CONGESTION (nasal congestion). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. On 26-Jan-2021, COUGH (cough) and NASAL CONGESTION (nasal congestion) outcome was unknown.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, COVID-19: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included Acetamide Fen, Tylenol, Advil   Reporter did not allow further contact